Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Is screening for osteoporosis worthwhile?

K Walker-Bone1, D M Reid, C Cooper

  • 1MRC Environmental Epidemiology Unit, Southampton General Hospital, UK.

British Medical Bulletin
|June 15, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Incidence of vertebral fracture in europe: results from the European Prospective Osteoporosis Study (EPOS).

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2002
Same author

Breast-feeding knowledge and attitudes of teenage mothers in Liverpool.

Journal of human nutrition and dietetics : the official journal of the British Dietetic Association·2002
Same author

Epidemiology of glucocorticoid-induced osteoporosis.

Frontiers of hormone research·2002
Same author

Quality management and the Emergency Services Enhancement Program.

Journal of quality in clinical practice·2002
Same author

Incidence and natural history of Paget's disease of bone in England and Wales.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2002
Same author

Aquarius: transitioning to an unmanned life support buoy.

Life support & biosphere science : international journal of earth space·2002
Same journal

Augmentation in Achilles tendon repair: evidence versus enthusiasm.

British medical bulletin·2026
Same journal

Regional musculoskeletal pain in workers-is the traditional medical model increasing disability?

British medical bulletin·2026
Same journal

Human health in relation to visible, functional, and accessible green space: a systematic review and narrative synthesis of the 3 + 30 + 300 guideline.

British medical bulletin·2026
Same journal

Muscle herniae in exercise-induced leg pain: diagnostic pitfalls and the 'repair paradox'.

British medical bulletin·2026
Same journal

Scaffolds and platelet concentrates in bone regenerative medicine: applications, mechanisms, and future approaches.

British medical bulletin·2026
Same journal

Back squat and deadlift fatiguing protocols elicit distinct countermovement jump profiles: phase-specific predictors and soreness responses.

British medical bulletin·2026
See all related articles

Osteoporosis causes fragility fractures, impacting global health and budgets. High-risk strategies targeting bone density screening and newer treatments show promise for fracture prevention in vulnerable populations.

Area of Science:

  • Gerontology
  • Orthopedics
  • Public Health

Background:

  • Osteoporosis is a prevalent condition characterized by fragility fractures, leading to significant mortality, morbidity, and global economic burden.
  • Predicted demographic shifts indicate an escalating impact on national healthcare budgets.
  • Fracture determinants include skeletal factors (peak bone mass, bone loss rate) and extra-skeletal factors (trauma response), with both genetic and modifiable environmental origins.

Purpose of the Study:

  • To explore strategies for preventing osteoporotic fractures.
  • To evaluate the effectiveness and economic viability of different prevention approaches, including population-wide measures and high-risk targeting.
  • To discuss the role of bone density screening and pharmacological interventions in managing osteoporosis.

Main Methods:

Related Experiment Videos

  • Review of existing literature on osteoporosis determinants and fracture prevention strategies.
  • Analysis of cost-effectiveness of high-risk approaches versus population-wide interventions.
  • Discussion of the predictive value of bone density measurements for fracture risk.
  • Consideration of compliance, risk-benefit balance, and treatment discontinuation for therapeutic interventions.

Main Results:

  • Bone density is a strong predictor of future fracture risk.
  • Cost-effectiveness analyses support high-risk strategies for pharmacological treatment targeting.
  • Concerns exist regarding therapeutic intervention compliance, risk-benefit profiles (e.g., hormone replacement therapy), and outcomes upon discontinuation.
  • Bone densitometry effectively predicts fractures, even in the elderly.

Conclusions:

  • High-risk strategies targeting individuals at greatest fracture risk are economically beneficial.
  • Current evidence does not support using hormone replacement therapy for menopausal women based solely on bone density screening.
  • Newer bone-specific agents administered later in life, closer to peak fracture incidence, warrant further research.
  • Future research should focus on high-risk strategies for agents like bisphosphonates and selective estrogen receptor modulators.